5-(1H-indol-3-yl)-6-phenyl-4,5-dihydro-1,2,4-triazin-3(2H)-one | 569655-96-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-(1H-indol-3-yl)-6-phenyl-4,5-dihydro-1,2,4-triazin-3(2H)-one
• 英文别名: 5-(1H-Indol-3-yl)-6-phenyl-4,5-dihydro-2H-[1,2,4]triazin-3-one；5-(1H-indol-3-yl)-6-phenyl-4,5-dihydro-2H-1,2,4-triazin-3-one
• CAS: 569655-96-5
• 化学式: C₁₇H₁₄N₄O
• 分子量: 290.324
• InChiKey: ROKSSOLVLOHHMN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  22
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  69.3
• 氢给体数：
  3
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  吲哚 、 6-phenyl-1,2,4-triazin-3-one 以 N,N-二甲基甲酰胺 为溶剂， 反应 1.0h， 以92%的产率得到5-(1H-indol-3-yl)-6-phenyl-4,5-dihydro-1,2,4-triazin-3(2H)-one
  参考文献：
  名称：

  吖嗪酮与 C-亲核试剂反应中的不对称诱导

  摘要：

  研究了酰化剂对 C-亲核试剂添加到 1,2,4-和 1,3,5-三嗪酮以及喹喔啉-2(1H)-one 过程中的影响。获得了一系列新的吖嗪酮衍生物。提出了一种在 N-Ts-L-氨基酸酰氯存在下制备吲哚到 1,2,4-三嗪酮和喹喔啉-2(1H)-one 的非对映异构纯加成产物的方法。

  DOI：

  10.1007/s11172-010-0195-z

文献信息

• Asymmetric induction in the reactions of azinones with C-nucleophiles
  作者：O. N. Chupakhin、I. N. Egorov、V. L. Rusinov、P. A. Slepukhin

  DOI：10.1007/s11172-010-0195-z

  日期：2010.5

  acylating agents on the course of addition of C-nucleophiles to 1,2,4- and 1,3,5-triazinones, as well as to quinoxalin-2(1H)-one, was studied. A series of new azinone derivatives was obtained. A method for the preparation of diastereomerically pure addition products of indoles to 1,2,4-triazinones and quinoxalin-2(1H)-one in the presence of N-Ts-L-amino acid acyl chlorides was suggested.

  研究了酰化剂对 C-亲核试剂添加到 1,2,4-和 1,3,5-三嗪酮以及喹喔啉-2(1H)-one 过程中的影响。获得了一系列新的吖嗪酮衍生物。提出了一种在 N-Ts-L-氨基酸酰氯存在下制备吲哚到 1,2,4-三嗪酮和喹喔啉-2(1H)-one 的非对映异构纯加成产物的方法。
• Methods of treating conditions associated with an EDG-4 receptor
  申请人：Solow-Cordero David

  公开号：US20050113283A1

  公开（公告）日：2005-05-26

  The present invention provides a method of modulating an Edg-4 receptor mediated biological activity in a cell. A cell expressing the Edg-4 receptor is contacted with a modulator of an Edg-4 receptor sufficient to modulate the Edg-4 receptor mediated biological activity. In another aspect, the present invention provides a method for modulating an Edg-4 receptor mediated biological activity in a subject. A therapeutically effective amount of a modulator of the Edg-4 receptor is administered to the subject.

  本发明提供了一种调节细胞中Edg-4受体介导的生物活性的方法。将表达Edg-4受体的细胞与足以调节Edg-4受体介导的生物活性的调节剂接触。在另一个方面，本发明提供了一种调节受体Edg-4介导的生物活性的方法。向受体施用治疗有效量的Edg-4受体调节剂。
• METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG RECEPTOR
  申请人：SRI INTERNATIONAL

  公开号：EP1513522A2

  公开（公告）日：2005-03-16
• [EN] METHODS OF TREATING CONDITIONS ASSOCIATED WITH AN EDG RECEPTOR<br/>[FR] PROCEDES POUR TRAITER DES PATHOLOGIES ASSOCIEES A UN RECEPTEUR D'EDG
  申请人：CERETEK LLC

  公开号：WO2003062392A2

  公开（公告）日：2003-07-31

  The present invention provides a method of modulating an Edg-2, Edg-3, Ed-4 or Edg7 receptor mediated biological activity in a cell. A cell expressing the Edg-2, Edg-3, Edg-4 or Edg 7 receptor is contacted with a modulator of the Edg-2, Edg-3, Ed-4 or Edg 7 receptor sufficient to modulate receptor mediated biological activity. In another aspect, the present invention provides a method for modulating an Edg-2, Edg-3, Ed-4 or Edg-7 receptor mediated biological in a subject. A therapeutically effective amount of a modulator of the Edg-2, Edg-3, Ed-4 or Edg7 receptor is administered to the subject.
• Egorov, Ilya N.; Tseitler, Tatyana A.; Zyryanov, Grigory V., ARKIVOC, 2011, vol. 2011, # 10, p. 312 - 323
  作者：Egorov, Ilya N.、Tseitler, Tatyana A.、Zyryanov, Grigory V.、Rusinov, Vladimir L.、Chupakhin, Oleg N.

  DOI：——

  日期：——